A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
Titel:
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group
Auteur:
Di Bartolomeo, M. Bajetta, E. Bochicchio, A.M. Carnaghi, C. Somma, L. Mazzaferro, V. Visini, M. Gebbia, V. Tumolo, S. Ballatore, P.